Skip to main content
WeightCited

Berberine para Insulin Resistance

A Evidencia Múltiples ensayos clínicos de gran tamaño muestran de forma consistente beneficios significativos.

Meta-analysis of 27 RCTs found significant improvements in fasting glucose, HbA1c, and insulin sensitivity. AMPK activation is comparable to metformin. A landmark RCT (n=116) showed 500 mg 3x/day reduced body weight by 3.6 kg and triglycerides by 35.9%.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dinsulin\u002Dresistance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Conclusión

Meta-analysis of 27 RCTs found significant improvements in fasting glucose, HbA1c, and insulin sensitivity. AMPK activation is comparable to metformin. A landmark RCT (n=116) showed 500 mg 3x/day reduced body weight by 3.6 kg and triglycerides by 35.9%.

Key Study Findings

Review
The role of traditional Chinese medicine in modulating gut microbiota to alleviating insulin resistance in …
Dose: None vs: None Outcome: PCOS insulin resistance via gut microbiota Efecto: None None

Población: Women with PCOS and insulin resistance

Review
Role of herbal medicine and gut microbiota in the prevention and treatment of obesity.
Dose: Various herbal medicines vs: None Outcome: Gut microbiota modulation in obesity Efecto: None None

Población: Obese population (herbal medicine review)

Review
Alkaloids as Promising Agents for the Management of Insulin Resistance: A Review.
Dose: None vs: None Outcome: inflammation markers Efecto: None None

Población: Healthy individuals

Review
Berberine interacts with gut microbiota and its potential therapy for polycystic ovary syndrome.
Dose: None vs: None Outcome: gut microbiota composition Efecto: None None

Población: None

Other
Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota …
Dose: None vs: None Outcome: Hepatic lipid, inflammation, gut microbiota Efecto: None None

Población: HFD-induced NAFLD rat model

Key Statistics

27

Estudios

2500

Participantes

Positive

A

Calificación

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
500 mg 2-3x/day with meals
starting:
500 mg/day and titrate
metabolicsupport:
1,000-1,500 mg/day

Límite superior: 1,500 mg/day; GI side effects limit intake; potential drug interactions

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
None -- Positive --
None -- Mixed --
Various herbal medicines -- Positive --
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Positive --

Mejor momento para tomar: With meals (reduces GI discomfort and synchronizes with postprandial glucose metabolism)

Safety & Side Effects

Efectos secundarios reportados

  • Diarrhea
  • Constipation
  • Flatulence
  • Abdominal pain
  • Potential hypoglycemia (when combined with diabetes medications)

Interacciones conocidas

  • Diabetes medications (may potentiate — hypoglycemia risk)
  • CYP3A4 substrates (berberine is a CYP3A4 inhibitor)
  • CYP2D6 substrates
  • Cyclosporine
  • Metformin (additive effects)

Ingesta máxima tolerable: 1,500 mg/day; GI side effects limit intake; potential drug interactions

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Berberine help with Insulin Resistance?
Based on 27 studies with 2,500 participants, there is strong evidence from multiple clinical trials that Berberine may support Insulin Resistance management. Our evidence grade is A (Strong Evidence).
How much Berberine should I take for Insulin Resistance?
Studies have used various dosages. A commonly studied range is 500 mg 2-3x/day with meals. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Berberine?
Reported side effects may include Diarrhea, Constipation, Flatulence, Abdominal pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Berberine and Insulin Resistance?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 27 peer-reviewed studies with 2,500 total participants. The overall direction of effect is positive.

References

  1. [1] Daniela Ciobârcă et al.. Pharmaceuticals (Basel). 2025. Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease. doi:10.3390/ph18020279 PubMed
  2. [2] Lin Yin et al.. Front Nutr. 2025. The role of traditional Chinese medicine in modulating gut microbiota to alleviating insulin resistance in polycystic ovary syndrome. doi:10.3389/fnut.2025.1700612 PubMed
  3. [3] Qiao Zhang et al.. J Ethnopharmacol. 2023. Role of herbal medicine and gut microbiota in the prevention and treatment of obesity. doi:10.1016/j.jep.2022.116127 PubMed
  4. [4] Ayoub Amssayef et al.. Curr Pharm Des. 2023. Alkaloids as Promising Agents for the Management of Insulin Resistance: A Review. doi:10.2174/0113816128270340231121043038 PubMed
  5. [5] Ting-Wei Zhu et al.. Clin Exp Pharmacol Physiol. 2023. Berberine interacts with gut microbiota and its potential therapy for polycystic ovary syndrome. doi:10.1111/1440-1681.13814 PubMed
  6. [6] Mingyue Zhong et al.. Food Funct. 2022. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats. doi:10.1039/d2fo01009g PubMed
  7. [7] Shi-Jun Yue et al.. Am J Physiol Endocrinol Metab. 2019. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids. doi:10.1152/ajpendo.00256.2018 PubMed

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.